IES Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that IES Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $3.37B | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $2.88B | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $2.38B | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | $2.17B | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | $1.54B | Dec 7, 2023 |
| FY2020 | Sep 30, 2020 | $330.41M | Dec 7, 2020 |
| FY2020 | Jun 30, 2020 | $293.13M | Dec 7, 2020 |
| FY2020 | Mar 31, 2020 | $291.28M | Dec 7, 2020 |
| FY2020 | Dec 31, 2019 | $276.04M | Dec 7, 2020 |
| FY2020 | Sep 30, 2019 | $293.61M | Dec 7, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $859.50M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $696.59M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $444.54M | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | $318.93M | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | $288.00M | Dec 7, 2023 |
| FY2020 | Sep 30, 2020 | $68.16M | Dec 7, 2020 |
| FY2020 | Jun 30, 2020 | $58.32M | Dec 7, 2020 |
| FY2020 | Mar 31, 2020 | $51.26M | Dec 7, 2020 |
| FY2020 | Dec 31, 2019 | $50.22M | Dec 7, 2020 |
| FY2020 | Sep 30, 2019 | $50.87M | Dec 7, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $305.98M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $219.12M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $108.29M | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | $34.76M | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | $66.66M | Dec 7, 2023 |
| FY2020 | Sep 30, 2020 | $14.61M | Dec 7, 2020 |
| FY2020 | Jun 30, 2020 | $12.26M | Dec 7, 2020 |
| FY2020 | Mar 31, 2020 | $6.23M | Dec 7, 2020 |
| FY2020 | Dec 31, 2019 | $8.50M | Dec 7, 2020 |
| FY2020 | Sep 30, 2019 | $9.86M | Dec 7, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $383.53M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $300.88M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $159.78M | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | $56.01M | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | $85.58M | Dec 7, 2023 |
| FY2022 | Sep 30, 2020 | $50.08M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $41.85M | Dec 3, 2021 |
| FY2020 | Sep 30, 2018 | $25.95M | Dec 7, 2020 |
| FY2019 | Sep 30, 2017 | $20.34M | Dec 6, 2019 |
| FY2018 | Sep 30, 2016 | $24.96M | Dec 7, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $474.98M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $396.68M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $298.63M | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | $262.71M | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | $202.25M | Dec 7, 2023 |
| FY2022 | Sep 30, 2020 | $170.91M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $140.58M | Dec 3, 2021 |
| FY2020 | Sep 30, 2018 | $123.92M | Dec 7, 2020 |
| FY2019 | Sep 30, 2017 | $120.37M | Dec 6, 2019 |
| FY2018 | Sep 30, 2016 | $100.56M | Dec 7, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $286.10M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $234.40M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $153.90M | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | $16.26M | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | $37.92M | Dec 7, 2023 |
| FY2022 | Sep 30, 2020 | $76.74M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $38.72M | Dec 3, 2021 |
| FY2020 | Sep 30, 2018 | $12.22M | Dec 7, 2020 |
| FY2019 | Sep 30, 2017 | $22.35M | Dec 6, 2019 |
| FY2018 | Sep 30, 2016 | $24.97M | Dec 7, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | $4.56M | Dec 7, 2018 |
| FY2018 | Sep 30, 2017 | $4.59M | Dec 7, 2018 |
| FY2018 | Sep 30, 2016 | $3.42M | Dec 7, 2018 |
| FY2017 | Sep 30, 2015 | $2.78M | Dec 8, 2017 |
| FY2016 | Sep 30, 2014 | $1.98M | Dec 9, 2016 |
| FY2015 | Sep 30, 2013 | $444.0K | Dec 11, 2015 |
| FY2014 | Sep 30, 2012 | $1.88M | Dec 12, 2014 |
| FY2013 | Sep 30, 2011 | $2.69M | Jan 6, 2014 |
| FY2012 | Sep 30, 2010 | $924.0K | Dec 14, 2012 |
| FY2011 | Sep 30, 2009 | $4.74M | Mar 30, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $1.60B | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $1.24B | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $981.60M | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | $934.71M | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | $766.62M | Dec 7, 2023 |
| FY2022 | Sep 30, 2020 | $560.53M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $445.26M | Dec 3, 2021 |
| FY2020 | Sep 30, 2018 | $421.99M | Dec 7, 2020 |
| FY2019 | Sep 30, 2017 | $424.49M | Dec 6, 2019 |
| FY2018 | Sep 30, 2016 | $394.34M | Dec 7, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $707.70M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $591.92M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $481.66M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $544.23M | Dec 7, 2023 |
| FY2022 | Sep 30, 2021 | $396.08M | Dec 6, 2022 |
| FY2021 | Sep 30, 2020 | $275.41M | Dec 3, 2021 |
| FY2020 | Sep 30, 2019 | $195.72M | Dec 7, 2020 |
| FY2019 | Sep 30, 2018 | $198.36M | Dec 6, 2019 |
| FY2018 | Sep 30, 2017 | $184.52M | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | $169.14M | Dec 8, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $883.96M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $611.11M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $449.99M | Nov 22, 2024 |
| FY2024 | Sep 30, 2022 | $361.29M | Nov 22, 2024 |
| FY2024 | Sep 30, 2021 | $345.95M | Nov 22, 2024 |
| FY2023 | Sep 30, 2020 | $283.31M | Dec 7, 2023 |
| FY2022 | Sep 30, 2019 | $246.25M | Dec 6, 2022 |
| FY2021 | Sep 30, 2018 | $220.41M | Dec 3, 2021 |
| FY2020 | Sep 30, 2017 | $236.70M | Dec 7, 2020 |
| FY2019 | Sep 30, 2016 | $223.41M | Dec 6, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $107.83M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $93.96M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $92.40M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $92.40M | Dec 7, 2023 |
| FY2022 | Sep 30, 2021 | $92.40M | Dec 6, 2022 |
| FY2022 | Sep 30, 2020 | $53.76M | Dec 6, 2022 |
| FY2021 | Sep 30, 2019 | $50.62M | Dec 3, 2021 |
| FY2020 | Sep 30, 2018 | $50.70M | Dec 7, 2020 |
| FY2019 | Sep 30, 2017 | $46.69M | Dec 6, 2019 |
| FY2018 | Sep 30, 2016 | $39.94M | Dec 7, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $800.82M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $497.76M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $295.78M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | $203.20M | Dec 7, 2023 |
| FY2022 | Sep 30, 2021 | $173.13M | Dec 6, 2022 |
| FY2021 | Sep 30, 2020 | $107.01M | Dec 3, 2021 |
| FY2020 | Sep 30, 2019 | $65.60M | Dec 7, 2020 |
| FY2019 | Sep 30, 2018 | $32.31M | Dec 6, 2019 |
| FY2018 | Sep 30, 2017 | $46.43M | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | $32.75M | Dec 8, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | $127.17M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | $100.83M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | $75.77M | Nov 22, 2024 |
| FY2018 | Sep 30, 2018 | $26.25M | Dec 7, 2018 |
| FY2018 | Sep 30, 2017 | $28.29M | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | $32.96M | Dec 8, 2017 |
| FY2016 | Sep 30, 2015 | $49.36M | Dec 9, 2016 |
| FY2016 | Sep 30, 2014 | $47.34M | Dec 9, 2016 |
| FY2016 | Sep 30, 2013 | $20.76M | Dec 9, 2016 |
| FY2015 | Sep 30, 2012 | $18.73M | Dec 11, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Sep 30, 2023 | $0 | Dec 7, 2023 |
| FY2023 | Sep 30, 2022 | $81.63M | Dec 7, 2023 |
| FY2016 | Sep 30, 2016 | $30.23M | Dec 9, 2016 |
| FY2016 | Sep 30, 2015 | $10.23M | Dec 9, 2016 |
| FY2015 | Sep 30, 2014 | $10.21M | Dec 11, 2015 |
| FY2014 | Sep 30, 2013 | $13.77M | Dec 12, 2014 |
| FY2013 | Sep 30, 2012 | $10.48M | Jan 6, 2014 |
| FY2012 | Sep 30, 2011 | $10.50M | Dec 14, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | 15 | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | 10 | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | 4 | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | 1 | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | 3 | Dec 7, 2023 |
| FY2020 | Sep 30, 2020 | 0 | Dec 7, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Dec 7, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Dec 7, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Dec 7, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Dec 7, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | 15 | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | 9 | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | 4 | Nov 21, 2025 |
| FY2024 | Sep 30, 2022 | 1 | Nov 22, 2024 |
| FY2023 | Sep 30, 2021 | 3 | Dec 7, 2023 |
| FY2020 | Sep 30, 2020 | 0 | Dec 7, 2020 |
| FY2020 | Jun 30, 2020 | 0 | Dec 7, 2020 |
| FY2020 | Mar 31, 2020 | 0 | Dec 7, 2020 |
| FY2020 | Dec 31, 2019 | 0 | Dec 7, 2020 |
| FY2020 | Sep 30, 2019 | 0 | Dec 7, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Sep 30, 2025 | 19.85M | Nov 21, 2025 |
| FY2024 | Sep 30, 2024 | 19.97M | Nov 21, 2025 |
| FY2024 | Sep 30, 2023 | 20.19M | Nov 22, 2024 |
| FY2023 | Sep 30, 2022 | 20.34M | Dec 7, 2023 |
| FY2022 | Sep 30, 2021 | 20.76M | Dec 6, 2022 |
| FY2021 | Sep 30, 2020 | 20.76M | Dec 3, 2021 |
| FY2020 | Sep 30, 2019 | 21.17M | Dec 7, 2020 |
| FY2019 | Sep 30, 2018 | 21.21M | Dec 6, 2019 |
| FY2018 | Sep 30, 2017 | 21.34M | Dec 7, 2018 |
| FY2017 | Sep 30, 2016 | 21.46M | Dec 8, 2017 |